Product NDC: | 10019-321 |
Proprietary Name: | Flumazenil |
Non Proprietary Name: | Flumazenil |
Active Ingredient(s): | .1 mg/mL & nbsp; Flumazenil |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10019-321 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076787 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100526 |
Package NDC: | 10019-321-01 |
Package Description: | 10 VIAL, MULTI-DOSE in 1 PACKAGE (10019-321-01) > 5 mL in 1 VIAL, MULTI-DOSE (10019-321-54) |
NDC Code | 10019-321-01 |
Proprietary Name | Flumazenil |
Package Description | 10 VIAL, MULTI-DOSE in 1 PACKAGE (10019-321-01) > 5 mL in 1 VIAL, MULTI-DOSE (10019-321-54) |
Product NDC | 10019-321 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Flumazenil |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20100526 |
Marketing Category Name | ANDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | FLUMAZENIL |
Strength Number | .1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Benzodiazepine Antagonist [EPC] |